Fig. 3From: Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trialChanges in mean weight (a), BMI (b), total lipoprotein cholesterol (c), low density lipoprotein cholesterol (d), and 8-OHdG (e) from baseline to 52 weeks in the exenatide and insulin groups. *P < 0.05; **P < 0.01 (compared to insulin group)Back to article page